NL-OMON51641尚未招募不适用
Pilot study to determine the intraTUMORal OsImertinib concentration in patients with peritoneal metastasizeD colorectal cancer (TUMOROID study) - TUMOROID study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Diagnosed with PM of CRC and candidate for CRS-HIPEC (GROUP 1)
- •- Diagnosed with liver metastasis of CRC and candidate for primary resection of
- •at least one liver metastasis (GROUP 2)
- •- 18 years or older
- •- WHO performance status 0 or 1
- •- Adequate haematologic and organ function
- •- Written informed consent
- •- Able to swallow oral medication
排除标准
- •- Not fit to undergo surgery
- •- The use of concomitant drugs that interact with osimertinib according to the
- •- An active contraindication for the use of osimertinib
- •- Mean resting corrected QT interval (QTc) > 470 msec at screening
- •- Medical history of interstitial lung disease
- •- Medical history of any skin disease
研究者
相似试验
尚未招募
不适用
A pilot study to measure the pressure of fluid present around cells of various solid cancer tumors.CTRI/2021/08/035470Tata Memorial Centre
终止
1 期
Exploratory Phase Ib/IIa Study of Intratumourally Administered Tigilanol Tiglate to Assess Safety, Tolerability and Tumour Response in Patients with Head and Neck Squamous Cell CarcinomaACTRN12619001407189QBiotics Group Limited19
Unknown
1 期
To study the Safety, Tolerability and Tumour Response when treated with drug Tigilanol Tiglate administered intratumourally in Patients with Head and Neck Squamous Cell Carcinoma.CTRI/2019/11/022032QBiotics Group Limited13
招募中
不适用
Pilot study on the determination of intratumoral concentrations of kinase inhibitors in patients with advanced solid malignanciesalle vormen van gevorderde, dwz inoperabele of uitgezaaide, solide tumorenAdvanced solid tumorsmetastasized/inoperable cancer10027655NL-OMON36159Vrije Universiteit Medisch Centrum35
进行中（未招募）
不适用
A Phase II Clinical Trial to Evaluate Intratumoral Injection of a Depot Formulation of Paclitaxel (DTS-301) as Neoadjuvant Therapy of Patients with Breast CancerInvasive primary breast cancerEUCTR2005-001417-18-ATDIATOS S.A.10